DOXYCIN TAB 100MG TABLET

Nazione: Canada

Lingua: inglese

Fonte: Health Canada

Compra

Scheda tecnica Scheda tecnica (SPC)
05-04-2018

Principio attivo:

DOXYCYCLINE (DOXYCYCLINE HYCLATE)

Commercializzato da:

LABORATOIRE RIVA INC.

Codice ATC:

J01AA02

INN (Nome Internazionale):

DOXYCYCLINE

Dosaggio:

100MG

Forma farmaceutica:

TABLET

Composizione:

DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100MG

Via di somministrazione:

ORAL

Confezione:

10/20/100/300

Tipo di ricetta:

Prescription

Area terapeutica:

TETRACYCLINES

Dettagli prodotto:

Active ingredient group (AIG) number: 0105569001; AHFS:

Stato dell'autorizzazione:

MARKETED

Data dell'autorizzazione:

1989-12-31

Scheda tecnica

                                _Prescribing Information – DOXYCIN CAPSULES AND DOXYCIN TABLETS_
_ _
_Page 1 of 25_
_ _
_ _
_ _
_ _
_ _
_ _
_ _
PRESCRIBING INFORMATION AND PATIENT MEDICATION INFORMATION
PR
DOXYCIN CAPSULES
100MG
Doxycycline Hyclate Capsules, USP
_100 mg doxycycline (as hyclate)_
PR
DOXYCIN TABLETS
100MG
Doxycycline Hyclate Tablets, USP
_100 mg doxycycline (as hyclate)_
Antibiotic
LABORATOIRE RIVA INC.
660 Industriel Blvd.
Blainville, Canada
J7C 3V4
www.labriva.com
Date of Revision:
April 5, 2018
Control #: 211564
_Prescribing Information – DOXYCIN CAPSULES AND DOXYCIN TABLETS_
_ _
_Page 2 of 25_
_ _
NAME OF DRUGS
PR
DOXYCIN CAPSULES
Doxycycline Hyclate Capsules, USP
_100mg doxycycline (as hyclate) _
PR
DOXYCIN TABLETS
Doxycycline Hyclate Tablets, USP
_100mg doxycycline (as hyclate)_
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
Doxycycline hyclate is a broad-spectrum antibiotic and is active
against a wide range of Gram-
negative and Gram-positive organisms. Doxycycline exerts its
bacteriostatic effect by the inhibition of
protein synthesis.
INDICATIONS AND CLINICAL USE
DOXYCIN CAPSULES AND DOXYCIN TABLETS
(doxycycline hyclate) may be indicated for
the treatment of:
Pneumonia:
Single and multilobe pneumonia and bronchopneumonia due to susceptible
strains of
_Streptococcus _
_pneunomiae_
and other
_Streptococcus_
spp.,
_Staphylococcus_
spp.,
_H. influenzae_
and
_Klebsiella _
_pneumoniae_
.
Other Respiratory Tract Infections:
Pharyngitis, tonsillitis, sinusitis, otitis media, bronchitis caused
by susceptible strains of β-hemolytic
_Streptococcus_
,
_Staphylococcus _
spp.,
_Streptococcus pneunomiae_
and
_H._
_influenzae_
.
Genitourinary Tract Infections:
Pyelonephritis, cystitis, urethritis caused by susceptible strains of
_Klebsiella_
spp.,
_Enterobacter _
_aerogenes, E. coli_
,
_Enterococcus_
spp.,
_Staphylococcus_
spp.,
_Streptococcus_
spp. and gonococcal
urethritis caused by
_Neisseria gonorrhoeae. _
In adult patients with urethritis, cervicitis and vaginitis with a
positive test for
_Chlamydia trachomatis_
and/or
_Ureapla
                                
                                Leggi il documento completo
                                
                            

Cerca alert relativi a questo prodotto